| Phase 12 trials |
|
Phase 1
|
NCT06748079 |
Dec 2024 → Sep 2025 |
chronic obstructive pulmonary disease |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT05051930 |
Oct 2021 → Oct 2022 |
chronic obstructive pulmonary disease |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Unknown
|
No outcome recorded
|
| Phase 24 trials |
|
Phase 2
|
NCT07252908 |
Dec 2025 → Apr 2026 |
chronic obstructive pulmonary disease |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT06527144 |
Sep 2024 → Jan 2025 |
chronic obstructive pulmonary disease |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT05987371 |
Aug 2023 → Jan 2024 |
chronic obstructive pulmonary disease |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT05292196 |
May 2022 → Jan 2023 |
chronic obstructive pulmonary disease |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Terminated
|
No outcome recorded
|
| Phase 32 trials |
|
Phase 3
|
NCT07464587 |
Mar 2026 → Feb 2027 expected |
chronic obstructive pulmonary disease |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT07147946 |
Sep 2025 → Mar 2027 expected |
chronic obstructive pulmonary disease |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|